Medical devices are made of metals, such as stainless steel, aluminum, and ceramic. Many of these materials are not compatible with body tissues and fluids and can cause complications such as infections and blood clots. According to the Centers for Disease Control and Prevention (CDC), around 2,000,000 patients contract hospital-acquired infections (HAIs) every year in the U.S., resulting in 100,000 deaths; HAIs cost the U.S. healthcare system an estimated USD 45 billion annually.
In addition, according to the European Centre for Disease, around 4,131,000 patients suffer from healthcare-associated infections every year in Europe. Rise in incidence of HAIs is a major challenge for healthcare providers; therefore, antimicrobial coatings have gained importance in recent years.
This research study analyzes and studies the business model of market players in terms of key partners, key activities, key resources, value propositions, channels, customer segments, customer relationships, revenue streams, and competitive strategy.
Business Model – A blueprint that ensures success of businesses, aligns operations with business strategies, improves process communication, increases control and consistency, improves operational efficiencies, offers competitive advantages, and amplifies revenues
Read More | Get the Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=137829340
The high rate of healthcare-associated infections (HAIs) is a major challenge for hospitals and healthcare providers across the globe. Medical devices can be a major source of HAIs and the use of antimicrobial coatings on a wide range of medical devices is an important measure to curb the growing rate of HAIs.
Globally, a number of factors such as the increasing risk of HAIs, rising geriatric population, technological advancements, and availability of funding form various government bodies is expected to trigger the growth of the antimicrobial coatings market for medical devices. However, limitations of silver-ion coatings, presence of time- and resource-intensive processes for the development and approval of antimicrobial coatings, and unfavorable healthcare reforms in the U.S. are restraining the growth of this market.
The antimicrobial coatings market for medical devices is marked by the presence of well-established firms as well as smaller firms. Some of the prominent players in the global antimicrobial coatings market include BASF SE (Germany), AST Products, Inc. (U.S.), BioInteractions LTD (U.K.), Covalon Technologies LTD (Canada), Sciessent LLC (U.S.), Royal DSM (Netherlands), Specialty Coating Systems, Inc. (U.S.), The Dow Chemical Company (U.S.), Hydromer, Inc. (U.S.), and PPG Industries, Inc. (U.S.).
This report provides in-depth assessment of the business models of leading companies (Specialty Coatings Systems, Inc. (SCS), Royal DSM, Hydromer, Inc., PPG Industries, Inc., and BASF SE) operating in the antimicrobial coatings market for medical devices. Manufacturers, start-up firms/entrepreneurs, resellers/channel partners/distributors (citing backward integration), market research & business consulting firms, and venture capitalists/investment firms are some of the key stakeholders who are likely to benefit from the business models of market players.
Feel FREE to Talk to Our Research Experts for More Detailed Info@
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=137829340
The research findings cited in this report encapsulate activities associated with designing a business, purchasing raw materials, manufacturing of products, finding and reaching customers, transacting a sale, distributing a product, or delivering a service. Manufacturing capabilities, R&D capabilities, logistic capabilities, distributor/supplier/sales channel networks, marketing & promotional activities, key resources, value propositions, key growth strategies, customer orientation/customer relationship management, pre- & post-sales services, customer segments, offices & warehouses, cost structures, and revenue streams, among other factors are some of the key attributes that are discussed at length in this report.
In addition, according to the European Centre for Disease, around 4,131,000 patients suffer from healthcare-associated infections every year in Europe. Rise in incidence of HAIs is a major challenge for healthcare providers; therefore, antimicrobial coatings have gained importance in recent years.
This research study analyzes and studies the business model of market players in terms of key partners, key activities, key resources, value propositions, channels, customer segments, customer relationships, revenue streams, and competitive strategy.
Business Model – A blueprint that ensures success of businesses, aligns operations with business strategies, improves process communication, increases control and consistency, improves operational efficiencies, offers competitive advantages, and amplifies revenues
Read More | Get the Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=137829340
The high rate of healthcare-associated infections (HAIs) is a major challenge for hospitals and healthcare providers across the globe. Medical devices can be a major source of HAIs and the use of antimicrobial coatings on a wide range of medical devices is an important measure to curb the growing rate of HAIs.
Globally, a number of factors such as the increasing risk of HAIs, rising geriatric population, technological advancements, and availability of funding form various government bodies is expected to trigger the growth of the antimicrobial coatings market for medical devices. However, limitations of silver-ion coatings, presence of time- and resource-intensive processes for the development and approval of antimicrobial coatings, and unfavorable healthcare reforms in the U.S. are restraining the growth of this market.
The antimicrobial coatings market for medical devices is marked by the presence of well-established firms as well as smaller firms. Some of the prominent players in the global antimicrobial coatings market include BASF SE (Germany), AST Products, Inc. (U.S.), BioInteractions LTD (U.K.), Covalon Technologies LTD (Canada), Sciessent LLC (U.S.), Royal DSM (Netherlands), Specialty Coating Systems, Inc. (U.S.), The Dow Chemical Company (U.S.), Hydromer, Inc. (U.S.), and PPG Industries, Inc. (U.S.).
This report provides in-depth assessment of the business models of leading companies (Specialty Coatings Systems, Inc. (SCS), Royal DSM, Hydromer, Inc., PPG Industries, Inc., and BASF SE) operating in the antimicrobial coatings market for medical devices. Manufacturers, start-up firms/entrepreneurs, resellers/channel partners/distributors (citing backward integration), market research & business consulting firms, and venture capitalists/investment firms are some of the key stakeholders who are likely to benefit from the business models of market players.
Feel FREE to Talk to Our Research Experts for More Detailed Info@
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=137829340
The research findings cited in this report encapsulate activities associated with designing a business, purchasing raw materials, manufacturing of products, finding and reaching customers, transacting a sale, distributing a product, or delivering a service. Manufacturing capabilities, R&D capabilities, logistic capabilities, distributor/supplier/sales channel networks, marketing & promotional activities, key resources, value propositions, key growth strategies, customer orientation/customer relationship management, pre- & post-sales services, customer segments, offices & warehouses, cost structures, and revenue streams, among other factors are some of the key attributes that are discussed at length in this report.
No comments:
Post a Comment